Parenteral Drug Association
Connecting People, Science and Regulation ®
by Rebecca Stauffer, PDA
On May 15, PDA submitted comments concerning the EU's template for GMP noncompliance statements.
The contents of "Risk-Benefit Analysis More of NCA Scope" are available to PDA members. Please sign up or log in to read the full article.
